Engineered bispecific antibodies boost macrophage killing of B-cell lymphoma
A new study describes a high-throughput strategy for engineering bispecific antibodies that could help macrophages destroy malignant B cells more ...
A new study describes a high-throughput strategy for engineering bispecific antibodies that could help macrophages destroy malignant B cells more ...
In a groundbreaking advancement at the nexus of immunotherapy and neuro-oncology, researchers from the UCLA Health Jonsson Comprehensive Cancer Center ...
Cancer immunotherapy has revolutionized oncology, empowering the immune system to detect and dismantle malignancies that once evaded traditional treatments. Despite ...
In a groundbreaking development that could revolutionize the treatment of one of the most lethal and treatment-resistant forms of ovarian ...
In a groundbreaking advancement poised to reshape the landscape of cancer immunotherapy, researchers have unveiled a novel strategy that harnesses ...
In an unprecedented convergence of synthetic biology and cancer immunotherapy, scientists from the Yong Loo Lin School of Medicine at ...
In an era where cancer treatment stands at the precipice of innovation, a remarkable breakthrough in radiotherapy and immunotherapy integration ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine